Perlancia Peptides
Perlancia Peptides restricts purchases to individuals conducting laboratory or institutional research and at least 21 years old. By entering, you confirm you meet this requirement.
All products offered on this website are sold strictly as research chemicals for in-vitro laboratory research use only. They are not drugs, foods, cosmetics, dietary supplements or medical devices, and they are not intended for human or veterinary consumption, diagnostic use, or therapeutic use of any kind.
Selecting “No” will take you away from this website. This confirmation will be remembered on this device for 30 days.
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue (GHS) and a selective agonist of the ghrelin receptor, formally designated as the growth hormone secretagogue receptor type 1a (GHS-R1a). The compound was developed in the late 1990s by researchers at Novo Nordisk as part of a broader investigation into synthetic growth hormone releasing […]
GHK-Cu, the copper complex of the tripeptide glycyl-L-histidyl-L-lysine (GHK), is a naturally occurring copper-binding peptide that was first identified in human plasma by Loren Pickart in 1973. The compound was initially characterized in the context of liver cell research, where it was observed to influence cellular behavior in ways that distinguished it from other plasma […]
CJC-1295 No DAC is a synthetic peptide analog of growth hormone-releasing hormone (GHRH), the endogenous hypothalamic peptide responsible for stimulating growth hormone secretion from the anterior pituitary gland. The compound is a modified version of the first 29 amino acids of native GHRH, designated GHRH(1-29), with several amino acid substitutions incorporated to improve metabolic stability […]
Body Protection Compound-157, commonly referred to as BPC-157, is a synthetic pentadecapeptide consisting of 15 amino acids. It was derived from a naturally occurring protein found in gastric juice and first described in the scientific literature during the 1990s through research conducted by Predrag Sikiric and colleagues at the University of Zagreb. The compound has […]
Growth hormone secretagogue peptides represent a well-characterized class of research compounds studied extensively for their interactions with the somatotropic axis. Scientific interest in this class emerged in the 1970s following the identification of endogenous growth hormone-releasing hormone (GHRH) and was further advanced in the 1980s and 1990s with the synthesis of ghrelin mimetics and the […]
Incretin-based peptides represent one of the most actively investigated compound classes in contemporary metabolic and endocrinological research. GLP-1 receptor agonist peptides, derived from or structurally related to native incretin hormones, have been subjects of significant scientific interest since the characterization of glucagon-like peptide-1 in the 1980s. Researchers studying pancreatic function, hypothalamic signaling, and metabolic pathway […]
